登录 注册 会员服务 联系我们

APC loss affects DNA damage repair causing doxorubicin resistance in breast cancer cells

  • Published:2019-12 Issue:12 Volume:21 Page:1143-1150
  • ISSN:1476-5586
  • Container-title:Neoplasia
  • language:en
  • Short-container-title:Neoplasia

Author:

Stefanski Casey D.,Keffler Kaitlyn,McClintock Stephanie,Milac Lauren,Prosperi Jenifer R.

Funder

American Cancer Society

ACS-Research Scholar Grant

Indiana Clinical and Translational Sciences Institute

National Institutes of Health

National Center for Advancing Translational Sciences

Clinical and Translational Sciences Award

Publisher

Elsevier BV

Subject

Cancer Research

Reference34 articles.

1. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61–70.

2. Aysola K, Desai A, Welch C, Xu J, Qin Y, Reddy V, et al. Triple negative breast cancer – an overview. Hereditary Genet. 2013;2013(Suppl 2).

3. New strategies for triple-negative breast cancer–deciphering the heterogeneity;Mayer;Clin Cancer Res,2014

4. Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins;Lovitt;BMC Cancer,2018

5. The molecular mechanisms of chemoresistance in cancers;Zheng;Oncotarget,2017
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3